China NMPA Product Recall - Indwelling intravenous needle

The National Medical Products Administration (NMPA) published a notification on January 13, 2017, detailing a voluntary product recall initiated by Shanghai Shangyi Kangge Medical Equipment Co., Ltd. The recall involves specific batches of the company's intravenous catheters. During an internal audit, the company discovered significant errors and omissions in the production records for certain batches of these catheters. This deficiency in record-keeping presented a potential risk of contamination within the affected products. In response to these findings, Shanghai Shangyi Kangge Medical Equipment Co., Ltd. decided to voluntarily recall the implicated intravenous catheters. This action is classified as a Level II recall, signifying that exposure to the product could lead to temporary or medically reversible adverse health consequences, or that the likelihood of serious adverse health consequences is remote. Detailed information regarding the models, specifications, and batch numbers of the affected products is available in the 'Medical Device Recall Event Report Form.' This proactive measure highlights the company's commitment to ensuring product safety and adherence to NMPA regulatory standards.